Australian judge dismisses lawsuit claiming Bayer's Roundup weedkiller causes cancerReuters • 07/25/24
Bayer announces positive topline results for NUBEQA® (darolutamide) from Phase III trial in men with metastatic hormone-sensitive prostate cancer (mHSPC)Business Wire • 07/17/24
Bayer and Kroger Team Up with Luke Bryan and Feeding America to Improve Access to Nutritious FoodBusiness Wire • 07/13/24
Bayer and Solynta Collaborate to Advance True Potato Seed in Smallholder MarketsBusiness Wire • 06/23/24
Bayer, maker of Roundup weedkiller, steps up fight against cancer-related lawsuitsMarket Watch • 05/22/24
Bayer presents latest data from oncology portfolio at 2024 ASCO Annual MeetingBusiness Wire • 05/16/24
Bayer Starts Phase I Study With Novel Targeted Radionuclide Therapy 225Ac-PSMA-Trillium in Advanced Metastatic Prostate CancerBusiness Wire • 05/15/24
Study Design and Baseline Characteristics of Prespecified, Exploratory Pooled Analysis to Investigate Effect of Finerenone on Cardio-Kidney Outcomes in Patients with CKD and Type 2 Diabetes and/or Heart Failure Shared at Heart Failure 2024 CongressBusiness Wire • 05/13/24
Bayer to Present Investigational Data from Comprehensive KERENDIA® (finerenone) Clinical Trial Program at Heart Failure 2024 CongressBusiness Wire • 05/10/24
WomenHeart and Bayer Join Forces to Enhance Heart Health Awareness and Education Among Women Across the U.S.Business Wire • 05/10/24
Bayer to unveil late-breaking data from Phase III OASIS 1 and 2 for elinzanetant in the treatment of vasomotor symptoms associated with menopauseBusiness Wire • 05/08/24
FourKites, Bayer and Graphic Packaging International to Present at Gartner Supply Chain Symposium/Xpo 2024Business Wire • 05/03/24